Home
>
National Drug Code (NDC)
>
ATORVASTATIN CALCIUM
ATORVASTATIN CALCIUM - 43063-453-30 - (ATORVASTATIN CALCIUM)
Drug Information of ATORVASTATIN CALCIUM
| Product NDC: | 43063-453 |
| Proprietary Name: | ATORVASTATIN CALCIUM |
| Non Proprietary Name: | ATORVASTATIN CALCIUM |
| Active Ingredient(s): | 40 mg/1 & nbsp; ATORVASTATIN CALCIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ATORVASTATIN CALCIUM
| Product NDC: | 43063-453 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090548 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120529 |
Package Information of ATORVASTATIN CALCIUM
| Package NDC: | 43063-453-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-453-30) |
NDC Information of ATORVASTATIN CALCIUM
| NDC Code | 43063-453-30 |
| Proprietary Name | ATORVASTATIN CALCIUM |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-453-30) |
| Product NDC | 43063-453 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ATORVASTATIN CALCIUM |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120529 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | ATORVASTATIN CALCIUM |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
